Clorox Company (The) (NYSE:CLX) – Investment analysts at Jefferies Group cut their Q1 2018 earnings per share estimates for shares of Clorox Company (The) in a research note issued on Thursday. Jefferies Group analyst K. Grundy now expects that the company will post earnings of $1.39 per share for the quarter, down from their previous forecast of $1.41. Jefferies Group currently has a “Hold” rating and a $132.00 target price on the stock. Jefferies Group also issued estimates for Clorox Company (The)’s Q2 2018 earnings at $1.32 EPS, Q3 2018 earnings at $1.22 EPS, FY2018 earnings at $5.55 EPS and FY2020 earnings at $6.25 EPS.
A number of other brokerages have also recently weighed in on CLX. BMO Capital Markets reissued an “outperform” rating on shares of Clorox Company (The) in a research note on Tuesday, September 12th. Barclays PLC reissued an “equal weight” rating and issued a $136.00 price target (down previously from $140.00) on shares of Clorox Company (The) in a research note on Friday, August 4th. BidaskClub cut Clorox Company (The) from a “hold” rating to a “sell” rating in a research note on Wednesday, July 5th. Zacks Investment Research raised Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 price target on the stock in a research note on Tuesday, July 4th. Finally, Royal Bank Of Canada reissued a “hold” rating and issued a $115.00 price target on shares of Clorox Company (The) in a research note on Friday, June 30th. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $127.39.
WARNING: This article was first posted by BBNS and is owned by of BBNS. If you are reading this article on another publication, it was stolen and reposted in violation of US & international copyright and trademark laws. The original version of this article can be accessed at https://baseballnewssource.com/markets/q1-2018-earnings-forecast-for-clorox-company-the-clx-issued-by-jefferies-group/1700282.html.
Shares of Clorox Company (NYSE:CLX) opened at 129.14 on Monday. The firm has a market capitalization of $16.67 billion, a PE ratio of 24.21 and a beta of 0.40. The firm’s 50 day moving average is $134.59 and its 200 day moving average is $134.61. Clorox Company has a 1-year low of $111.24 and a 1-year high of $141.76.
Clorox Company (The) (NYSE:CLX) last released its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The company had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.65 billion. During the same period last year, the company earned $1.30 EPS. The firm’s revenue for the quarter was up 2.9% compared to the same quarter last year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, November 13th. Shareholders of record on Wednesday, October 25th will be paid a dividend of $0.84 per share. The ex-dividend date of this dividend is Tuesday, October 24th. This represents a $3.36 annualized dividend and a yield of 2.60%. Clorox Company (The)’s dividend payout ratio (DPR) is presently 63.04%.
In other Clorox Company (The) news, COO Dawn C. Willoughby sold 2,158 shares of Clorox Company (The) stock in a transaction dated Tuesday, August 29th. The stock was sold at an average price of $138.00, for a total transaction of $297,804.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Jon M. Balousek sold 9,223 shares of Clorox Company (The) stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $138.87, for a total value of $1,280,798.01. Following the transaction, the senior vice president now directly owns 20,614 shares in the company, valued at approximately $2,862,666.18. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 21,242 shares of company stock worth $2,944,449. Company insiders own 1.00% of the company’s stock.
Hedge funds and other institutional investors have recently made changes to their positions in the stock. American Beacon Advisors Inc. bought a new stake in shares of Clorox Company (The) in the 1st quarter valued at approximately $104,000. Parkside Financial Bank & Trust grew its stake in shares of Clorox Company (The) by 3.8% in the 2nd quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock valued at $107,000 after buying an additional 29 shares in the last quarter. Valley National Advisers Inc. grew its stake in shares of Clorox Company (The) by 0.6% in the 1st quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock valued at $116,000 after buying an additional 5 shares in the last quarter. Sun Life Financial INC grew its stake in shares of Clorox Company (The) by 10,344.4% in the 2nd quarter. Sun Life Financial INC now owns 940 shares of the company’s stock valued at $125,000 after buying an additional 931 shares in the last quarter. Finally, Blue Chip Partners Inc. grew its stake in shares of Clorox Company (The) by 3.9% in the 2nd quarter. Blue Chip Partners Inc. now owns 941 shares of the company’s stock valued at $125,000 after buying an additional 35 shares in the last quarter. 71.33% of the stock is owned by institutional investors and hedge funds.
About Clorox Company (The)
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with our FREE daily email newsletter.